Publication details

ATTRA - clinical registry for monitoring effectiveness and safety of biological therapies for rheumatic diseases in Czech Republic: more than 10-years experience

Authors

HEJDUK Karel PAVELKA Karel ZÁVADA Jakub UHER Michal VENCOVSKÝ Jiří PAVELKA Karel JARKOVSKÝ Jiří

Year of publication 2012
Type Appeared in Conference without Proceedings
Citation
Description Arthritis - in all of its forms - is the leading cause of disability in developed countries. The clinical registry ATTRA was created in 2001 in the Czech Republic as a tool for continuous monitoring and assessment of clinical parametres in patients with rheumatic diseases (rheumatoid arthritis – RA, ankylosing spondylitis – AS, psoriatic arthritis – PSA, and juvenile idiopathic arthritis – JIA) who have been treated with biological therapies.

You are running an old browser version. We recommend updating your browser to its latest version.

More info

By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Settings

Necessary Only Accept Cookies